EUVIMEDEUVIMED entdecken
Open Access · CC0

Targeted solutions to increase dolutegravir coverage, viral load testing coverage, and viral suppression among children living with HIV in Togo: An analysis of routine facility data

Caterina Casalini iD, Yema D'Almeida iD, Moussa Ariziki Nassam, Essopha Kokoloko, Souley Wade, Jean Paul Tchupo, Messan Damarly, Justin Mandala, Michele Lanham, Natasha Mack, Chris Akolo, Vincent Polakinam Pitche und 2 weitere

PLOS ONE · 21.12.2023 · 18 (12) · e0296293

DOI: 10.1371/journal.pone.0296293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 21.12.2023. Verfasst von Caterina Casalini und 13 weiteren Autor:innen. Beteiligte Einrichtung: HIV Programs, FHI 360, Hilversum, Netherlands. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: USAID/PEPFAR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background According to UNAIDS, Togo halved AIDS-related deaths among children ages 0–14 from 2010 to 2020. However, available data show low dolutegravir (DTG)-containing antiretroviral therapy (ART) coverage and low viral load suppression (VLS) among children living with HIV (CLHIV). We analyzed routine facility data before and after implementation of root-cause-based solutions for improving DTG coverage, viral load (VL) testing coverage, and VLS among CLHIV. Description We analyzed routine data for CLHIV ≤14 years from October 2019 through September 2022. We assessed proportion of CLHIV on ART receiving DTG, VL testing coverage (CLHIV on ART with documented VL test result), and VLS (CLHIV with documented VL test result of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsChildHumansViral LoadTogoRetrospective StudiesDolutegravir

Substanzen

Anti-HIV AgentsDolutegravir

Autor:innen und Institutionen

  • HIV Programs, FHI 360, Hilversum, Netherlands.
  • WAMERO, FHI 360, Lomé, Togo.
  • HIV Programs, FHI 360, Durham, NC, United States of America.
  • National AIDS Council, Lomé, Togo.
  • USAID/West Africa, Accra, Greater Accra Region, Ghana.
  • National AIDS Program, Lomé, Togo.

ORCID-Profile: Caterina Casalini, Yema D'Almeida

Förderung

  • USAID/PEPFAR

Zitieren

APA

Casalini, C., D'Almeida, Y., Nassam, M. A., Kokoloko, E., Wade, S., Tchupo, J. P., Damarly, M., Mandala, J., Lanham, M., Mack, N., Akolo, C., Pitche, V. P., Guidigbi, H., & Dagnra, C. A. (2023). Targeted solutions to increase dolutegravir coverage, viral load testing coverage, and viral suppression among children living with HIV in Togo: An analysis of routine facility data. PLOS ONE, 18(12), e0296293. https://doi.org/10.1371/journal.pone.0296293

Vancouver

Casalini C, D'Almeida Y, Nassam MA, Kokoloko E, Wade S, Tchupo JP, et al. Targeted solutions to increase dolutegravir coverage, viral load testing coverage, and viral suppression among children living with HIV in Togo: An analysis of routine facility data. PLOS ONE. 2023;18(12):e0296293. doi:10.1371/journal.pone.0296293

BibTeX
@article{Casalini2023,
  author = {Casalini, Caterina and D'Almeida, Yema and Nassam, Moussa Ariziki and Kokoloko, Essopha and Wade, Souley and Tchupo, Jean Paul and Damarly, Messan and Mandala, Justin and Lanham, Michele and Mack, Natasha and Akolo, Chris and Pitche, Vincent Polakinam and Guidigbi, Hugues and Dagnra, Claver Anoumou},
  title = {Targeted solutions to increase dolutegravir coverage, viral load testing coverage, and viral suppression among children living with HIV in Togo: An analysis of routine facility data},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {12},
  pages = {e0296293},
  doi = {10.1371/journal.pone.0296293}
}
Kostenlos starten →